151 related articles for article (PubMed ID: 37783406)
1. Molecular networking unveils anti-SARS-CoV-2 constituents from traditionally used remedies.
Wasilewicz A; Bojkova D; Beniddir MA; Cinatl J; Rabenau HF; Grienke U; Rollinger JM; Kirchweger B
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117206. PubMed ID: 37783406
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-severe acute respiratory syndrome coronavirus 2 effect of Ephedra przewalskii Stapf extract.
Kakimoto M; Nomura T; Nazmul T; Yamamoto A; Sasaki H; Higashiura A; Ito M; Ohge H; Mikage M; Ogawa KO; Sakaguchi T
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117341. PubMed ID: 37879507
[TBL] [Abstract][Full Text] [Related]
3. Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.
Nair MS; Huang Y; Fidock DA; Polyak SJ; Wagoner J; Towler MJ; Weathers PJ
J Ethnopharmacol; 2021 Jun; 274():114016. PubMed ID: 33716085
[TBL] [Abstract][Full Text] [Related]
4. Chemical profiling and unraveling of anti-COVID-19 biomarkers of red sage (Lantana camara L.) cultivars using UPLC-MS/MS coupled to chemometric analysis, in vitro study and molecular docking.
Darwish RS; El-Banna AA; Ghareeb DA; El-Hosseny MF; Seadawy MG; Dawood HM
J Ethnopharmacol; 2022 Jun; 291():115038. PubMed ID: 35151836
[TBL] [Abstract][Full Text] [Related]
5. Bioactive Azadirachta indica and Melia azedarach leaves extracts with anti-SARS-CoV-2 and antibacterial activities.
Hemdan BA; Mostafa A; Elbatanony MM; El-Feky AM; Paunova-Krasteva T; Stoitsova S; El-Liethy MA; El-Taweel GE; Abu Mraheil M
PLoS One; 2023; 18(3):e0282729. PubMed ID: 36888689
[TBL] [Abstract][Full Text] [Related]
6. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
[TBL] [Abstract][Full Text] [Related]
7. Screening and evaluation of cytotoxicity and antiviral effects of secondary metabolites from water extracts of Bersama abyssinica against SARS-CoV-2 Delta.
Zekeya N; Mamiro B; Ndossi H; Mallya RC; Kilonzo M; Kisingo A; Mtambo M; Kideghesho J; Chilongola J
BMC Complement Med Ther; 2022 Oct; 22(1):280. PubMed ID: 36289484
[TBL] [Abstract][Full Text] [Related]
8. Discovery and characterization of the covalent SARS-CoV-2 3CL
Zhang YN; Zhu GH; Liu W; Xiong Y; Hu Q; Zhuang XY; Jia GH; Zhang WD; Ge GB
Phytomedicine; 2023 Jun; 114():154796. PubMed ID: 37037086
[TBL] [Abstract][Full Text] [Related]
9.
El Gizawy HA; Boshra SA; Mostafa A; Mahmoud SH; Ismail MI; Alsfouk AA; Taher AT; Al-Karmalawy AA
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641388
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus.
Derksen A; Kühn J; Hafezi W; Sendker J; Ehrhardt C; Ludwig S; Hensel A
J Ethnopharmacol; 2016 Jul; 188():144-52. PubMed ID: 27178637
[TBL] [Abstract][Full Text] [Related]
11. Discovery of anti-SARS-CoV-2 secondary metabolites from the heartwood of
Wasilewicz A; Zwirchmayr J; Kirchweger B; Bojkova D; Cinatl J; Rabenau HF; Rollinger JM; Beniddir MA; Grienke U
Front Mol Biosci; 2023; 10():1202394. PubMed ID: 37347040
[TBL] [Abstract][Full Text] [Related]
12. The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro.
Ngwe Tun MM; Toume K; Luvai E; Nwe KM; Mizukami S; Hirayama K; Komatsu K; Morita K
J Nat Med; 2022 Mar; 76(2):402-409. PubMed ID: 35006524
[TBL] [Abstract][Full Text] [Related]
13. Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.
Singh M; Trivedi D; Mohapatra R; Bagchi T; Durthi CP; Kuppam C
Curr Pharm Des; 2021 Oct; 27(31):3389-3398. PubMed ID: 34225610
[TBL] [Abstract][Full Text] [Related]
14. In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea.
Bajrai LH; El-Kafrawy SA; Hassan AM; Tolah AM; Alnahas RS; Sohrab SS; Rehan M; Azhar EI
Sci Rep; 2022 Dec; 12(1):21723. PubMed ID: 36522420
[TBL] [Abstract][Full Text] [Related]
15. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
Idrees M; Khan S; Memon NH; Zhang Z
Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
[TBL] [Abstract][Full Text] [Related]
16. The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.
Shahzad F; Anderson D; Najafzadeh M
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854262
[TBL] [Abstract][Full Text] [Related]
17. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
18. Discovery of naturally occurring inhibitors against SARS-CoV-2 3CL
Xiong Y; Zhu GH; Wang HN; Hu Q; Chen LL; Guan XQ; Li HL; Chen HZ; Tang H; Ge GB
Fitoterapia; 2021 Jul; 152():104909. PubMed ID: 33894315
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2.
Plante KS; Dwivedi V; Plante JA; Fernandez D; Mirchandani D; Bopp N; Aguilar PV; Park JG; Tamayo PP; Delgado J; Shivanna V; Torrelles JB; Martinez-Sobrido L; Matos R; Weaver SC; Sastry KJ; Newman RA
Biomed Pharmacother; 2021 Jun; 138():111457. PubMed ID: 33721754
[TBL] [Abstract][Full Text] [Related]
20. Anti-respiratory syncytial virus and anti-herpes simplex virus activity of six Tanzanian medicinal plants with extended studies of Erythrina abyssinica stem bark.
Mollel JT; Said JS; Masalu RJ; Hannoun C; Mbunde MVN; Nondo RSO; Bergström T; Trybala E
J Ethnopharmacol; 2022 Jun; 292():115204. PubMed ID: 35304278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
